Background: Polypharmacy and adverse drug side effects are among the high-risk causes for falls in older adults.Objective: To assess the association between polypharmacy and the risk of recurrent falls and different pharmacological groups of drugs with falls.Setting: University hospital in community-dwelling older adults in Turkey.Method: Falls risk-increasing drugs were identified as Cardiovascular drugs, Analgesics, Central Nervous System (CNS) drugs, Endocrine drugs, and others. Falls were evaluated as to whether absent or present during the past 12 months. Two or more falls were recorded as a recurrent faller.Main outcome measure: Low hand grip strength (HGS) increased the risk of fall approximately 1.7 times (Odds Ratio (OR) 1.69 95% CI 1.11-2.58). Older age and using angiotensin-converting enzyme inhibitors (ACE-I) increased the risk of recurrent falls (OR 1.05: 95% CI 1.00-1.09 and OR 4.04: 95% CI 1.70-9.60, respectively).Results: Patients' mean (SD) age was 71.9 (7.5) years, and 71.0% of them were female. While 87 (51.4%) participants fall once, 82 (48.5%) of participants reported recurrent falls. Two hundred and eighty-eight (55.6%) participants had four or more prescribed medications. The percentage of patients who used at least one PIM on admission, as defined by the Beers criteria, was 155 (29.9%). Conclusion: Although the polypharmacy rate of the participants was high, there was no significant relationship between polypharmacy and falling. But low HGS, one of the components of sarcopenia, was a risk factor for fall, and older age and use of ACE-I were risk factors for recurrent fall.